Suchergebnisse - "Berdel, Andrew F"

PubPharm (11)

1

A randomized phase 2 trial of nintedanib and low-dose cytarabine in elderly patients with acute myeloid leukemia ineligible for intensive chemotherapy

enthalten in: Annals of hematology | 2023

von Berdel, A. | Koch, R. | Gerss, J. | +15

2

A randomized phase 2 trial of nintedanib and low-dose cytarabine in elderly patients with acute myeloid leukemia ineligible for intensive chemotherapy

enthalten in: Annals of hematology | 2022

von Berdel, A. | Koch, R. | Gerss, J. | +15

3

A randomized phase 2 trial of nintedanib and low-dose cytarabine in elderly patients with acute myeloid leukemia ineligible for intensive chemotherapy

enthalten in: Annals of hematology | 2022

von Berdel, A. | Koch, R. | Gerss, J. | +15

4

Using stroma-anchoring cytokines to augment ADCC : a phase 1 trial of F16IL2 and BI 836858 for posttransplant AML relapse

enthalten in: Blood advances | 2022

von Berdel, A. | Ruhnke, L. | Angenendt, L. | +21

5

Multiparametric Magnetic Resonance Imaging for Immediate Target Hit Assessment of CD13-Targeted Tissue Factor tTF-NGR in Advanced Malignant Disease

enthalten in: Cancers | 2021

von Gerwing, M. | Krähling, T. | Schliemann, C. | +10

6

Dose escalation and expansion phase I studies with the tumour-targeting antibody-tumour necrosis factor fusion protein L19TNF plus doxorubicin in patients with advanced tumours, including sarcomas

enthalten in: European journal of cancer (Oxford, England : 1990) | 2021

von Schliemann, C. | Hemmerle, T. | Berdel, A. | +12

7

Targeting Tissue Factor to Tumor Vasculature to Induce Tumor Infarction

enthalten in: Cancers | 2021

von Berdel, A. | Schwöppe, C. | Brand, C. | +10

8

Phase I study of F16IL2 antibody-cytokine fusion with very low-dose araC in acute myeloid leukaemia relapse after allogeneic stem cell transplantation

enthalten in: British journal of haematology | 2021

von Schliemann, C. | Kessler, T. | Berdel, A. | +10

9

Phase I study of F16IL2 antibody–cytokine fusion with very low‐dose araC in acute myeloid leukaemia relapse after allogeneic stem cell transplantation

enthalten in: British Journal of Haematology | 2021

von Schliemann, C. | Kessler, T. | Berdel, A. | +10

10

Animal Safety, Toxicology, and Pharmacokinetic Studies According to the ICH S9 Guideline for a Novel Fusion Protein tTF-NGR Targeting Procoagulatory Activity into Tumor Vasculature : Are Results Predictive for Humans?

enthalten in: Cancers | 2020

von Berdel, W. | Harrach, S. | Brand, C. | +5